| |
| |
|
| Insider
Information: |
Hanna John Walter Jr |
| Relationship: |
Officer, Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
562,113 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,674,904 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
562,113 |
|
|
| Total
Value |
$6,674,904 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Chief Commercial Officer |
2020-11-06 |
74,309 |
|
0 |
Premium* |
|
|
Caredx, Inc. |
CDNA |
Officer, Director |
2024-04-15 |
487,804 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CDNA |
Caredx, Inc. |
President & CEOOfficer |
• • – |
2024-04-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
487,804 |
|
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-11-06 |
4 |
AS |
$43.40 |
$923,106 |
D/D |
(21,250) |
74,309 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-11-06 |
4 |
OE |
$20.21 |
$429,463 |
D/D |
21,250 |
95,559 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-11-05 |
4 |
AS |
$40.00 |
$260,651 |
D/D |
(6,406) |
74,309 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-11-05 |
4 |
OE |
$5.98 |
$47,902 |
D/D |
6,406 |
80,715 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-09-02 |
4 |
D |
$34.16 |
$11,102 |
D/D |
(325) |
74,309 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-08-31 |
4 |
AS |
$33.37 |
$1,883,550 |
D/D |
(56,443) |
74,634 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-08-31 |
4 |
OE |
$4.00 |
$475,978 |
D/D |
56,443 |
131,077 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-08-21 |
4 |
OE |
$8.86 |
$12,404 |
D/D |
1,400 |
76,034 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-08-21 |
4 |
AS |
$36.00 |
$50,405 |
D/D |
(1,400) |
74,634 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-31 |
4 |
AS |
$36.12 |
$509,145 |
D/D |
(14,095) |
74,634 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-31 |
4 |
OE |
$8.86 |
$124,882 |
D/D |
14,095 |
88,729 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-21 |
4 |
AS |
$32.36 |
$21,131 |
D/D |
(653) |
74,524 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-21 |
4 |
OE |
$2.40 |
$1,567 |
D/D |
653 |
75,177 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-20 |
4 |
AS |
$32.05 |
$361,993 |
D/D |
(11,294) |
74,524 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• • – |
2020-07-20 |
4 |
OE |
$2.40 |
$27,106 |
D/D |
11,294 |
85,818 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2020-06-02 |
4 |
D |
$26.01 |
$8,453 |
D/D |
(325) |
74,524 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
265 |
74,849 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2020-03-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,888) |
74,584 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2020-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(997) |
77,472 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
78,469 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2019-12-06 |
4 |
AS |
$30.09 |
$295,995 |
D/D |
(9,838) |
65,275 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2019-12-06 |
4 |
OE |
$9.05 |
$89,034 |
D/D |
9,838 |
75,113 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2019-12-05 |
4 |
AS |
$30.01 |
$243,047 |
D/D |
(8,100) |
65,275 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Commercial Officer |
• – – |
2019-12-05 |
4 |
OE |
$9.05 |
$73,305 |
D/D |
8,100 |
73,375 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
